RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

aoe. True the 3 cent price of the placement. Look at the stock chart. Before the stock was placed the 200 day M.A. of CORX was around 4.8 to 4.9 cents. Three cents being about a 38 percent discount to that price. And that was for a little more than a hundred million shares. If an investor wanted to buy a half billion shares, he'd certainly want a discount of at least the same magnitude to the current S.P. of .23. Hence my estimate of .20 cents for 1/2 billion shares seems rather generous.
My point is that CORX will need to look at avenues to fund human trials other than stock offerings.
Once the trails commence it may be that the share price will appreciate to a point where offerings will make sense, but not at current share price levels.